Overcoming some Limiting Factors in Tumour Immunotherapy

Immunotherapy using rat 7s antibodies against plasmacytoma 5563 in C3H mice has been measured carefully. Prior adsorption of antibodies with normal mouse tissues, and supplements of co-optable non-immunized macrophages and lymphocytes enhanced the scope of immunotherapy against established tumours....

Descripción completa

Detalles Bibliográficos
Autores principales: Fakhri, O., Hobbs, J. R.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1973
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009036/
https://www.ncbi.nlm.nih.gov/pubmed/4724609
_version_ 1782136033558659072
author Fakhri, O.
Hobbs, J. R.
author_facet Fakhri, O.
Hobbs, J. R.
author_sort Fakhri, O.
collection PubMed
description Immunotherapy using rat 7s antibodies against plasmacytoma 5563 in C3H mice has been measured carefully. Prior adsorption of antibodies with normal mouse tissues, and supplements of co-optable non-immunized macrophages and lymphocytes enhanced the scope of immunotherapy against established tumours. It is suggested that available co-optable lymphocytes and macrophages are imporant limiting factors in tumour immunotherapy. IMAGES:
format Text
id pubmed-2009036
institution National Center for Biotechnology Information
language English
publishDate 1973
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20090362009-09-10 Overcoming some Limiting Factors in Tumour Immunotherapy Fakhri, O. Hobbs, J. R. Br J Cancer Articles Immunotherapy using rat 7s antibodies against plasmacytoma 5563 in C3H mice has been measured carefully. Prior adsorption of antibodies with normal mouse tissues, and supplements of co-optable non-immunized macrophages and lymphocytes enhanced the scope of immunotherapy against established tumours. It is suggested that available co-optable lymphocytes and macrophages are imporant limiting factors in tumour immunotherapy. IMAGES: Nature Publishing Group 1973-07 /pmc/articles/PMC2009036/ /pubmed/4724609 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Articles
Fakhri, O.
Hobbs, J. R.
Overcoming some Limiting Factors in Tumour Immunotherapy
title Overcoming some Limiting Factors in Tumour Immunotherapy
title_full Overcoming some Limiting Factors in Tumour Immunotherapy
title_fullStr Overcoming some Limiting Factors in Tumour Immunotherapy
title_full_unstemmed Overcoming some Limiting Factors in Tumour Immunotherapy
title_short Overcoming some Limiting Factors in Tumour Immunotherapy
title_sort overcoming some limiting factors in tumour immunotherapy
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009036/
https://www.ncbi.nlm.nih.gov/pubmed/4724609
work_keys_str_mv AT fakhrio overcomingsomelimitingfactorsintumourimmunotherapy
AT hobbsjr overcomingsomelimitingfactorsintumourimmunotherapy

Ejemplares similares